Pharmacokinetic study on adenomatous prostate tissue concentrations of cefoperazone. Clinical efficacy and patient tolerance of intramuscular cefoperazone treatment of chronic bacterial prostatitis.

Abstract:

:Cephalosporins do not reach active therapeutical concentrations in the prostatic tissue in patients suffering from chronic bacterial prostatitis. Cefoperazone is an exception. Its efficacy in the treatment of chronic bacterial prostatitis in 20 patients was studied and the concentrations, obtained after intramuscular administration, evaluated in patients who underwent transurethral operation due to prostatic hypertrophy (in 14 patients). The cefoperazone concentrations in the prostate have been evaluated 60, 90 and in some cases 120 min after the administration of the drug and compared to those obtained in serum. The clinical cure has been obtained in 16 patients. The average drug concentration in the prostate after 60 min was 22.8 +/- 13.6 versus 39.8 +/- 20.0 micrograms/ml in serum; 90 min after administration the average concentration in the prostate was 23.2 +/- 14.1 versus 35.7 +/- 18.1 micrograms/ml in serum. The correlation was significant both at 60 min (r = 64, p less than 0.05) and at 90 min (r = 64, p less than 0.05).

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Melloni D,Ammatuna P,Formica P,Falletta V,Gaglio F,Cacciatore M,Messina G

doi

10.1159/000238704

subject

Has Abstract

pub_date

1989-01-01 00:00:00

pages

410-5

issue

6

eissn

0009-3157

issn

1421-9794

journal_volume

35

pub_type

杂志文章
  • Changes of surface hydrophobicity and charge of Staphylococcus aureus treated with sub-MIC of antibiotics and their effects on the chemiluminescence response of phagocytic cells.

    abstract::The effects of the sub-MIC of antibiotics on the surface hydrophobicity and charge of Staphylococcus aureus were examined by the contact angle method and by microscopic electrophoresis, and the production of oxygen-derived radicals by mouse peritoneal macrophages was measured by a luminol-chemiluminescence assay. The ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239327

    authors: Nomura S,Kuroiwa A,Nagayama A

    更新日期:1995-03-01 00:00:00

  • Role of vitamin A in prevention and treatment of sarcoma 180 in mice.

    abstract::The effect of deficiency of vitamin A and its supplementation on growth of murine sarcoma 180 was evaluated. The efficacy of cyclophosphamide under depleted and supplemented condition of the vitamin was also scrutinized. Supplemental vitamin A helped to check progression of tumour growth and also increased the effecti...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238497

    authors: Ghosh J,Das S

    更新日期:1987-01-01 00:00:00

  • Rifampicin in free combination with other antimicrobial drugs in non-Tb infections. Clinical data on 650 patients (a review).

    abstract::A review of the published literature has allowed the identification of a number of non-tubercular indications where rifampicin (trade mark Ciba-Geigy: Rimactane) has been successfully used in combination with other chemotherapeutic agents. The cases reviewed with regard to effectiveness sum 562. The most frequently co...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000238006

    authors: Kissling M,Bergamini N

    更新日期:1981-01-01 00:00:00

  • Pharmacokinetics of miocamycin in patients with liver cirrhosis.

    abstract::The pharmacokinetics of miocamycin, a new macrolide antibiotic, was studied in 6 healthy controls and 6 patients with compensated liver cirrhosis. The results indicate that in chronic liver disease the kinetics of the drug is altered. Therefore, a dosage adjustment of miocamycin is recommended when dealing with these ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238690

    authors: Miglioli PA,Pivetta P,Orlando R,Palatini P,Varotto A,Okolicsanyi L

    更新日期:1989-01-01 00:00:00

  • Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.

    abstract::Fleroxacin, a new long-acting quinolone, induces rapid killing and bacterial filamentation as do other quinolones. Ten strains of Escherichia coli were exposed comparatively to fleroxacin and ampicillin in order to determine the effect of sub- and supra-inhibitory concentrations of each of these two compounds on turbi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238706

    authors: Yourassowsky E,Van der Linden MP,Crokaert F

    更新日期:1989-01-01 00:00:00

  • Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria.

    abstract::A method is described which may be used to compare the relative activity of beta-lactam antibiotics against gram-negative bacilli. The method offers several important advantages over conventional methods of evaluation of the antibacterial activity of beta-lactam agents: the bacterial inoculum is simply and accurately ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221965

    authors: Greenwood D

    更新日期:1977-01-01 00:00:00

  • Activity assays of thiadiazine derivatives on Trichomonas vaginalis and amastigote forms of Trypanosoma cruzi.

    abstract::Eight thiadiazine 1,1-dioxide derivatives were evaluated for antitrichomonal and antitrypanosomal activities. In vivo tests were performed on a murine model for trichomoniasis standardized in our laboratory. The capacity of compounds to clear visceral lesions in experimentally infected animals as well as their effects...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239040

    authors: Atienza J,Martínez Díaz RA,Gómez Barrio A,Escario JA,Herrero A,Ochoa C,Rodríguez J

    更新日期:1992-01-01 00:00:00

  • Vancomycin plus imipenem ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy.

    abstract::137 patients with febrile neutropenia after cytotoxic therapy not responding to ceftazidime plus or ceftriaxone plus netilmicin in received additionally to the previous combination either vancomycin alone or combined with another anti-gram-negative compound: imipenem in those treated prophylactically with ofloxacin an...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239434

    authors: Lacka J,Oravcova E,Sevcikova L,Studena M,Bachanova V,Kukuckova E,Spanik S,Sufliarsky J,Helpianska L,Trupl J,Kunova A,Vochyanova I,Sycova Z,Grey E,Krcméry V Jr

    更新日期:1996-03-01 00:00:00

  • Tapering and discontinuation of glucocorticoid prophylaxis during prolonged weekly to biweekly paclitaxel administration.

    abstract:BACKGROUND:Taxanes cause hypersensitivity reactions, averted by premedication with H1 blockers and high glucocorticoid (GC) doses. Prolonged weekly taxane administration may lead to GC toxicity. PURPOSE:To determine whether patients not hypersensitive to initial paclitaxel (PTX) infusion after high-dose GC premedicati...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000085618

    authors: Braverman AS,Rao S,Salvatti ME,Adamson B,McManus M,Pierre S

    更新日期:2005-05-01 00:00:00

  • Comparative study of the sensitivity of lymphoblastoid and transformed monocytic cell lines to the cytotoxic effects of Viscum album extracts of different origin.

    abstract::Viscum album (VA) preparations consist of aqueous extracts of V. album, the European mistletoe. VA extracts contain mistletoe lectins, which are members of the ribosome-inactivating protein type II family. VA preparations have cytotoxic and immunomodulatory properties. Cytotoxicity induced by VA extracts may differ gr...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000074530

    authors: Duong Van Huyen JP,Delignat S,Kazatchkine MD,Kaveri SV

    更新日期:2003-12-01 00:00:00

  • Ciprofloxacin in the treatment of malignant external otitis.

    abstract::Malignant external otitis is a serious infection most frequently caused by Pseudomonas aeruginosa. Because of its antipseudomonal activity and good tissue penetration, ciprofloxacin is an antibiotic which should, in theory, be effective in the treatment of this type of infection. Publications on the use of ciprofloxac...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000239315

    authors: Gehanno P

    更新日期:1994-01-01 00:00:00

  • Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20.

    abstract::The treatment of diffuse large B-cell lymphoma in the presence of cardiac comorbidities can be challenging considering that the standard treatment regimen used for this aggressive subtype of non-Hodgkin lymphoma (NHL) consists of a combination of rituximab, cyclophosphamide, doxorubicin hydrochloride, Oncovin (vincris...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000452756

    authors: Alrifai T,Grant Szymanski K,Venugopal P,Mahon B,Okwuosa T,Karmali R

    更新日期:2017-01-01 00:00:00

  • Fluoropyrimidine-Associated Toxicity in Two Gastrointestinal Cancer Patients: Potential Role of Common DPYD Polymorphisms.

    abstract::While the majority of patients can be treated safely with fluoropyrimidine, some experience severe fluoropyrimidine-associated toxicity. The frequency and severity of these adverse events vary from patient to patient and are partially explained by genetic polymorphism into the dihydropyrimidine dehydrogenase (DPYD) ge...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000477333

    authors: Falvella FS,Luoni M,Cheli S,Fava S,Cergnul M

    更新日期:2017-01-01 00:00:00

  • 5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with advanced pancreatic cancer who have progressed on gemcitabine-based therapy.

    abstract:BACKGROUND/AIMS:There is no standard consensus on a strategy in the second-line setting for gemcitabine-refractory advanced pancreatic cancer. This study evaluated the activity and tolerability of oxaliplatin, irinotecan, 5-fluorouracil and leucovorin (FOLFIRINOX) as a second-line therapy in advanced pancreatic adenoca...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000356158

    authors: Lee MG,Lee SH,Lee SJ,Lee YS,Hwang JH,Ryu JK,Kim YT,Kim DU,Woo SM

    更新日期:2013-01-01 00:00:00

  • Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.

    abstract:BACKGROUND:Levofloxacin and tobramycin, alone and in combination with cefepime, were investigated for their in vitro activities and post-antibiotic effects (PAEs) on Pseudomonas aeruginosa. METHODS:The in vitro activities of tobramycin and levofloxacin in combination with cefepime were determined by microbroth chequer...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000265128

    authors: Ozbek B,Otuk G

    更新日期:2009-01-01 00:00:00

  • In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.

    abstract::A multicenter study aimed at assessing the in vitro activity of sulbactam/ampicillin against a wide range of bacterial pathogens was performed using 2,209 clinical strains, all recently collected from inpatients in seven Italian centers and preliminarily screened as being ampicillin-resistant and beta-lactamase produc...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1159/000238760

    authors: Varaldo PE,Ripa S,Nicoletti G,Covelli I,Satta G,Carlone N,Fontana R

    更新日期:1990-01-01 00:00:00

  • Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.

    abstract:BACKGROUND:Bacterial endotoxin is known to act as a potent trigger of disseminated coagulation and septic shock. During clinical antibiotic treatment, endotoxin may be released from Gram-negative bacteria. It is known that antibiotic classes differ in their ability to induce endotoxin release. AIM:It was the aim of th...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000321622

    authors: Trautmann M,Scheibe C,Wellinghausen N,Holst O,Lepper PM

    更新日期:2010-01-01 00:00:00

  • Experimental combination chemotherapy: intracarotid versus intravenous administration of aziridinylbenzoquinone, BCNU, and cisplatin in dogs.

    abstract::Sixteen adult beagles (10-12 kg) were used to evaluate combinations of 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ, aziridinylbenzoquinone), 1,3-bis-2-chloroethyl-1-nitrosourea (BCNU, carmustine), and cis-dichlorodiammineplatinum(II) (CDDP, cisplatin) administered by intravenous or intracarotid infu...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238532

    authors: Wright KC,Stephens LC,Wallace S,Savaraj N,Feun LG

    更新日期:1987-01-01 00:00:00

  • Hepatic arterial infusion with irinotecan in patients with liver metastases of colorectal cancer: results of an extended phase I study.

    abstract:BACKGROUND:To define the maximum tolerated dose (MTD) tolerability and efficacy of intra-arterial chemotherapy with irinotecan in patients with liver metastases of colorectal carcinoma (CRC). METHODS:Superselective intra-arterial irinotecan was applied on days 1, 14, 28 and 42. The initial dose was 140 mg/m² with esca...

    journal_title:Chemotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000348579

    authors: Eichler K,Dufas T,Hammerstingl R,Gruber-Rouh T,Vogl TJ,Zangos S

    更新日期:2013-01-01 00:00:00

  • Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone.

    abstract::After metabolization, erdosteine (a mucoactive drug) produces an active metabolite (Met I) with an SH group that is capable of opening disulphide bonds, including those of pilin, a protein of bacterial fimbriae. This induces stereochemical conformational changes that interfere with the binding of bacterial adhesins (f...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000063223

    authors: Braga PC,Zuccotti T,Dal Sasso M

    更新日期:2001-05-01 00:00:00

  • Combined effects of S-1, a new form of oral tegafur, plus modulators on ovarian cancer in nude rats.

    abstract::We evaluated the efficacy of S-1 as a new oral antitumor agent in ovarian cancer-bearing nude rats. This drug consists of tegafur, 5-chloro-2,4-dihydroxypyridine, and oxonic acid in a molar ratio of 1:0.4:1.S-1 was given alone or in combination with cisplatin. When administered alone at a daily dose of 20 mg/ kg, S-1 ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239479

    authors: Suzuki M,Sekiguchi I,Sato I,Shirasaka T

    更新日期:1996-11-01 00:00:00

  • Treatment of community-acquired pneumonia.

    abstract::Lower respiratory tract infections are the major cause of death due to infectious disease in the developed and developing world. Despite substantial progress in defining pathogens and in therapeutic options, there continues to be major controversies in the clinical management of these infections. This report reviews t...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000048489

    authors: Bartlett J

    更新日期:2000-01-01 00:00:00

  • Antiproliferative effect of somatostatin and analogs.

    abstract::Over the past decade, antiproliferative effects of somatostatin and analogs have been reported in many somatostatin receptor-positive normal and tumor cell types. Regarding the molecular mechanisms involved, somatostatin or analogs mediate their action through both indirect and direct effects. Somatostatin acts throug...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000049159

    authors: Bousquet C,Puente E,Buscail L,Vaysse N,Susini C

    更新日期:2001-01-01 00:00:00

  • Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.

    abstract::Neither cefoperazone, cefotaxime, mezlocillin nor piperacillin significantly killed intraphagocytic bacteria of representative assay strains of Serratia marcescens, as determined with 55 vol% of fresh defibrinated human blood treated with 2 mg/ml of phenylbutazone, which permitted phagocytic ingestion of bacteria, but...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238173

    authors: Traub WH

    更新日期:1983-01-01 00:00:00

  • Serum concentrations and adverse effects of chloramphenicol in pediatric patients.

    abstract::Chloramphenicol serum concentration is often monitored to assure efficacy and prevent toxicity. We studied the relationship between steady-state chloramphenicol serum concentration and hematologic adverse effects in 45 pediatric patients. The mean peak serum concentration of chloramphenicol in patients with and withou...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238516

    authors: Nahata MC

    更新日期:1987-01-01 00:00:00

  • 5-Fluorocytosine kinetics in patients with acute renal failure undergoing continuous hemofiltration.

    abstract::The pharmacokinetic disposition of 5-fluorocytosine (5-FC) was studied in 7 patients with acute renal failure undergoing continuous hemofiltration (CH). CH was performed with a high-flux membrane and the average filtration rate (FR) was 16.3 ml/min. Following an intravenous loading dose of 2,500 mg, 5-FC concentration...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238478

    authors: Ittel TH,Legler UF,Polak A,Glöckner WM,Sieberth HG

    更新日期:1987-01-01 00:00:00

  • Immunotoxicity of cephalosporins in mice.

    abstract::This study was performed in female B6C3F1 mice to confirm previously observed effects of selected cephalosporin antibiotics on nonspecific immunity, and to determine possible effects on specific acquired immunity and host resistance. Mice were treated intravenously with DQ-2556, ceftizoxime or ceftezole at 800 mg/kg/d...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239137

    authors: Furuhama K,Benson RW,Knowles BJ,Roberts DW

    更新日期:1993-07-01 00:00:00

  • Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.

    abstract:BACKGROUND:In this study (part of the global TEST program), the in vitro activity of tigecycline, a member of a new class of antimicrobial agents, the glycylcyclines, against clinical isolates collected in Italy was evaluated. METHODS:A total of 200 clinical isolates were collected and identified in our institution du...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000112415

    authors: Roveta S,Marchese A,Debbia EA

    更新日期:2008-01-01 00:00:00

  • In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).

    abstract::The in vitro activities of quinupristin/dalfopristin (Synercid), ampicillin, erythromycin, clarithromycin, vancomycin, teicoplanin, ciprofloxacin and tetracycline were examined and compared against 526 gram-positive bacteria. The minimal inhibitory concentrations (MICs) for quinupristin/dalfopristin against Staphyloco...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048530

    authors: Ling TK,Fung KS,Cheng AF

    更新日期:2001-07-01 00:00:00

  • In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.

    abstract::The in vitro activity of sparfloxacin, a new fluoroquinolone, was compared with ciprofloxacin and ofloxacin against 166 consecutive isolates from the upper respiratory tract of outpatients. The strains were fully susceptible to three quinolones. The antibacterial activity of sparfloxacin was comparable or better than ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238970

    authors: Malmborg AS,Ahlén S

    更新日期:1993-01-01 00:00:00